1,451
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Potential of mucoadhesive chitosan glutamate microparticles as microbicide carriers – antiherpes activity and penetration behavior across the human vaginal epithelium

, , , , , & show all
Pages 2278-2288 | Received 26 Jul 2021, Accepted 04 Oct 2021, Published online: 20 Oct 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Wei Yin & Liqiong Ding. (2023) Nanocarrier-Based Drug-Delivery System in Herpes Simplex Virus Treatment. Future Virology 18:2, pages 129-135.
Read now

Articles from other publishers (6)

Tayo Alex Adekiya, Mumuni Sumaila, Raphael Taiwo Aruleba & Yahya E. Choonara. 2023. Viral Drug Delivery Systems. Viral Drug Delivery Systems 91 117 .
Anna Czajkowska-Kośnik, Emilia Szymańska & Katarzyna Winnicka. (2022) Nanostructured Lipid Carriers (NLC)-Based Gel Formulations as Etodolac Delivery: From Gel Preparation to Permeation Study. Molecules 28:1, pages 235.
Crossref
Emilia Szymańska, Michał Wojasiński, Justyna Dąbrowska, Małgorzata Krzyżowska, Magdalena Nowicka, Tomasz Ciach & Katarzyna Winnicka. (2022) Chitosan-poly(ethylene oxide) nanofibrous mat as a vaginal platform for tenofovir disoproxyl fumarate – The effect of vaginal pH on drug carrier performance. International Journal of Biological Macromolecules 222, pages 856-867.
Crossref
Joanna Kurczewska. (2022) Recent Reports on Polysaccharide-Based Materials for Drug Delivery. Polymers 14:19, pages 4189.
Crossref
Emilia Szymańska, Michał Wojasiński, Robert Czarnomysy, Renata Dębowska, Iwona Łopianiak, Kamil Adasiewicz, Tomasz Ciach & Katarzyna Winnicka. (2022) Chitosan-Enriched Solution Blow Spun Poly(Ethylene Oxide) Nanofibers with Poly(Dimethylsiloxane) Hydrophobic Outer Layer for Skin Healing and Regeneration. International Journal of Molecular Sciences 23:9, pages 5135.
Crossref
Chao-Chin Hsu, Isabel Hsu, Li-Hsuan Lee, Rosie Hsu, Yuan-Shuo Hsueh, Chih-Ying Lin & Hui Hua Chang. (2022) Ovarian Follicular Growth through Intermittent Vaginal Gonadotropin Administration in Diminished Ovarian Reserve Women. Pharmaceutics 14:4, pages 869.
Crossref